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 The detection of nucleic acid biomarkers in 
point-of-care diagnostics is currently limited by 
technical complexity, cost, and time constraints. 
However, to overcome these shortcomings, a solution 
can potentially be realized through the combined use of 
isothermal nucleic acid amplification, programmable 
nucleic acid circuitry, and a standard pregnancy test. 
First, loop-mediated isothermal amplification (LAMP) 
of pathogenic nucleic acids can be used to specifically 
enhance the presence of target biomarkers found in 
circulating nucleic acid (CNA) samples from bodily 
fluids that include blood, saliva, and urine. Once 
amplified, the mechanics of one-step toehold-mediated 
strand displacement (OSD) reactions can be used to 
detect subsequent LAMP amplicon product. By 
targeting a single-stranded loop LAMP amplicon 
region, a controlled and complementary OSD probe 
can be produced such that one strand of the reporter is 
biotinylated and another bears the hormone hCG. In the 
presence of LAMP amplicons, hCG-bearing strands 
from the OSD probes can then be released on the basis 
of strand displacement activity. The subsequent 
changes in free-hCG can then be measured using a 
commercial pregnancy test. Currently, results have 
demonstrated the success of this diagnostic pathway 
using a three-way junction hCG-OSD probe to detect 
synthetic biomarker samples both in buffered solution 
and in human serum. This overarching method can thus 
have the potential to be applied to any nucleic acid 
biomarker target, offering a broad and hopeful future 





Nucleic Acid Biomarkers as Point-Of-Care Diagnostic 
Targets 
 
In modern medicine, the need to develop point-
of-care diagnostics can prove pivotal in the spread of 
healthcare to areas of low-resource and poor 
socioeconomic bearing. The simplistic needs of point-
of-care devices limit their use to a small range of 
biological analytes, preventing their current 
implementation in the detection of certain pathogenic 
biomarkers. One such target that has been 
unfortunately blocked from the benefits of point-of-
care diagnostics lies in nucleic acid biomarkers. In 
traditional medicine, nucleic acids are frequently used 
in the diagnosis of diseases that span viral, bacterial, 
and cancerous origins. Despite the commonality of 
nucleic acid biomarkers in clinical diagnostics, two 
issues currently hinder their viability for detection in 
point-of-care settings. First, nucleic acid biomarkers 
are often found in trace amounts throughout bodily 
samples. In a typical diagnostic sample from a human 
patient, pathogenic nucleic acids can be found in what 
is known as circulating nucleic acid (CNA). This 
reservoir of nucleic acids is a mixture of DNA and 
RNA that arises as a minute byproduct of cell 
degradation or apoptosis within the body and can be 
observed in fluid samples such as blood, saliva, and 
urine. The result, however, is the presence of a complex 
sample matrix, heavy dilution factors, and competing 
nucleic acids that can all attribute to low amounts of 
target nucleic acid biomarker available for detection. 
Fortunately, this problem can be easily overcome with 
appropriate resources by utilizing one of several 
methods available to selectively amplify target nucleic 
acids. Despite this, the second issue therein lies in 
producing a signal that is capable of reflecting the 
amount of amplified target nucleic acid in a product-
specific manner. In most cases, nucleic acid 
visualization methods are infrequently target-specific 
(e.g: gel electrophoresis, pyrophosphate release, etc.) 
and thus provide signal in the presence of any nucleic 
acid. This provides complexity in the case of nucleic 
acid amplification reactions, which oftentimes generate 
non-specific side products which can clutter signal. To 
again overcome this issue, target-specific nucleic acid 
visualization systems exist and can be used, but rely 
heavily on experimentally and technologically 
advanced methods that require highly trained 
individuals and expensive machinery, such as real-time 
PCR. These techniques not only carry a high price tag, 
but are also time-consuming and lack field robustness.  
As a result, the capability to detect nucleic acid 
biomarkers is clouded by its overall complexity, cost, 
and timing.  
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 With this in mind, if nucleic acid biomarkers 
are to be detected under point-of-care settings, it is 
necessary to develop or modify a new schematic of 
molecular diagnostics. To make this viable, the two 
main issues that must again be addressed are the ability 
to amplify target nucleic acids and the ability to 
produce a signal transduction method that is specific to 
the amplified target.  
 
Isothermal Nucleic Acid Amplification 
 
 In considering the two issues at hand when 
dealing with point-of-care nucleic acid detection, the 
problem of amplification is perhaps better dealt with 
and explored. Through current advances in 
biotechnology, there is wide array of amplification 
reactions that exist for nucleic acids. Of these methods, 
however, the ones best suited for use in point-of-care 
diagnostic settings most likely lie within the range of 
isothermal amplification (IsoT) techniques. Unlike 
traditional PCR, isothermal amplification reactions do 
not rely on cycling temperature changes to undergo 
nucleic acid amplification. Instead, thermodynamic 
favorability from base-pairing is used in combination 
with DNA polymerase strand-displacement activity to 
drive seemingly autonomous polymerization circuits. 
By being held at only a single temperature, isothermal 
amplification reactions offer a decreased need in 
complex machinery used relative to traditional PCR 
methods. As such, isothermal amplification is typically 
much cheaper and less technical, matching well with 
the requirements of point-of-care diagnostics.  
 Thus, with the potential solution for dealing 
with trace amounts of biomarker lying within 
isothermal nucleic acid amplification, it is important to 
consider which type of isothermal reaction to use when 
observing downstream applications. Several isothermal 
reaction schemes exist, including: rolling circle 
amplification(RCA), strand displacement 
amplification (SDA), loop-mediated isothermal 
amplification (LAMP), and many others. Of these 
options, LAMP is likely the most suitable for point-of-
care use as it offers increases in sensitivity, reaction 
speed, and amplicon yield above most other methods. 
Furthermore, it can be applied to non-denatured 
genomic DNA samples under isothermal reaction 
conditions, which has shown to be widely useful in 
genetic diagnostics and point-of-care device 
fabrication.  
 Overall, LAMP offers powerful nucleic acid 
detection capabilities. Under controlled conditions, it 
has been demonstrated to detect as few as two starting 
molecules within reaction volumes paralleled to 
standard point-of-care diagnostic samples (being 
within the microliter range.) The LAMP reaction 
involves a six-primer configuration that ultimately 
generates a combination of both spurious and target-
specific side products (Figure 1,A&B). As is the case 
with any isothermal continuous amplification reaction 
such as LAMP, the formation of side product 
amplicons can provide cluttering signals that add to the 
difficulty in using non-target-specific amplification 
detection. LAMP, however, offers the benefit in that 
one of the amplicons that is generated as a byproduct 
of this reaction is a semi-duplex dumbbell DNA 
structure composed of two target-specific single-
stranded loops (Figure 1, C). Two variants of this type 
of amplicon are formed for a total of four individual 
and distinct loop regions. 
Thus, by using LAMP, the issue of low target 
nucleic acid biomarker concentrations is overcome as 
the amplification reaction can produce extensive fold-
increases in product. Using LAMP also continues to 
maintain a point-of-care focus due to the requirement 
of using only a single reaction temperature. 
Furthermore, the single-stranded loop amplicons 
generated as one of the side-products of LAMP can 
further act as a platform for amplification detection in 
a target-specific manner. Combining these factors 
together, LAMP can promisingly help solve the first 
issue to point-of-care nucleic acid recognition while 
similarly building the foundation to address the second, 
more challenging concern of transducing a signal from 
the amplified product.   
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One-Step Toehold-Mediated Strand-Displacement  
 
With the selection of LAMP as an amplification 
method, there is thus a pressing need to develop a real-
time, sequence-specific, and robust method for 
monitoring LAMP that can readily separate true signal 
from non-specific noise in a point-of-care setting.  One 
potential solution for this could come from the use of 
nucleic acid circuits. Nucleic acid circuits are enzyme-
free systems that are synthetically designed to perform 
desired logic functions (such as the AND or OR 
functions found in computer programming.)  In 
developing various schemes, appropriate circuit 
function has been shown to be dependent on the 
slightest defects in circuit design, including those from 
DNA structures or even from minute sequence 
differences as small as single nucleotide 
polymorphisms (SNPs). Most circuits are based on the 
idea of toehold-mediated strand displacement, in which 
thermodynamic favorability of base-pairing drives 
spontaneous exchanges of strand-binding between 
various single-stranded and semi-duplex nucleic acid 
structures (Figure 2). By consequence, this system can 
thus be exploited for use in the signal transduction of 
LAMP amplicons, which similarly bear necessary 
single-stranded loop regions. Sequence-specific 
partial-duplexed nucleic acid structures termed one-
step toehold-mediate strand-displacement (OSD) 
probes can be created such that they bear a 
complementary strand to a target loop region of a 
LAMP amplicon. Increased complementarity of the 
partially-duplexed probe can then serve to selectively 
release a strand of less complementary nucleic acid in 










the	 green	 domain)	 at	 5’	 termini	 of	 component	 B.	 Increased	
thermodynamic	favorability	of	the	binding	between	‘A’	and	‘B’	causes	for	
the	disassembly	of	the	double	stranded	region	of	‘B’.	The	final	product	is	
a	 highly	 complementary	 duplex	 structure	 that	 resulted	 from	 the	
hybridization	of	‘A’	and	‘B,’	termed	‘C,’	and	the	released	fragment	once	
hybridized	to	‘B,’	termed	‘D.’		
hCG OSD-Probes and the Commercial Pregnancy Test 
 
While OSD probes are highly programmable 
and sequence-specific, the single release of a non-
complementary strand of nucleic acid still does not 
provide enough signal transduction to visualize LAMP 
amplification of a target nucleic acid biomarker.  As 
such, there is a need to further modify OSD probes such 
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is measurable in low-resource and point-of-care 
settings. One potential way to achieve this could be 
through integration of a commercial pregnancy test into 
the entire detection system. For several decades, 
pregnancy tests have found their place on the shelves 
of local markets and drugstores across the world. As a 
diagnostic device, these tests are perhaps one of the 
most commonly recognized and commercially 
available point-of-care diagnostics available in the 
market to date. The popularity of this device is likely 
linked to the simplicity of its use. To perform its 
function, a typical pregnancy test is able to detect a 
glycoprotein hormone known as human chorionic 
gonadotropin (hCG), which is released in elevated 
levels by the placenta and is readily found in the blood 
and urine of pregnant women throughout the duration 
of pregnancy.  
hCG detection in a pregnancy test is achieved 
by what is known as a lateral flow 
immunochromatographic assay. Such assays can be 
split into two separate components that individually 
contribute to the detection of a target analyte. The first 
section is the loading pad and is the area in which a 
fluid sample is administered to. Furthermore, the 
loading pad contains antibodies which are capable of 
selectively binding in excess to the target analyte and 
are also modified such that they are conjugated to gold 
nanoparticles (AuNPs). These AuNPS provide the pink 
coloration that can later be used to visually signal for 
the location of these primary anti-analyte antibodies. 
Further from the loading pad, the second section of the 
assay is the conjugate pad and is further subdivided into 
the test line and the control line. Similar to the loading 
pad, the test line portion of the conjugate pad contains 
anti-analyte antibodies that are capable of specifically 
binding to different epitopes on the target analyte 
relative to the primary antibody. These secondary anti-
analyte antibodies on the test line, however, are 
conjugated to the pad itself and are thus immobilized 
on the strip in a single band. Further downstream from 
the test line is the control line section of the conjugate   
pad. Again, a series of antibodies are uniformly 
immobilized on the control line; however, these 
antibodies are designed to specifically bind to an inert 
epitope on the primary anti-antigen antibody in both the 
native and immunocomplexed form.  
 Clinical samples are added to a lateral flow 
assay strip to detect for the presence of certain 
biologically relevant analytes. This can be put into the 
perspective of a standard pregnancy test, in which the 
diagnostic biomarker analyte is hCG. In the case where 
a sample is added from an individual with hCG present 
in the body, the hormone is first able to interact and 
bind with the primary anti-hCG antibody which then 
forms the hCG-antibody immunocomplex. Capillary 
flow carries the mixture down the test strip where it 
then reaches the secondary anti-hCG antibodies that are 
uniformly embedded on the conjugated pad. If hCG 
and the subsequent immunocomplex are present, the 
secondary anti-hCG antibodies can capture the 
immunocomplexes, sandwiching the hCG between the 
two antibodies. As a result of this, the gold 
nanoparticles conjugated to the primary antibody are 
localized on a single band, producing the first pink 
“test” band on the test line. Excess primary antibodies 
and the remaining immunocomplexes further flow 
down the strip where they reach the control line. Since 
the control line binds to the primary antibody 
regardless of its binding to hCG, the second pink 














analyte	 antibodies	 that	 are	 conjugated	 to	 gold	 nanoparticles.	 Lateral	
flow	 down	 the	 test	 strip	 brings	 complexes	 and	 remaining	 unbound	
antibodies	to	the	test	line,	where	secondary	anti-analyte	antibodies	can	
again	bind	 the	analyte	and	 localize	gold	nanoparticles	 in	a	 single	 line.	
Continuous	 flow	 draws	 the	 sample	 further	 down	 the	 strip	 where	
antibodies	capture	additional	primary	anti-analyte	antibodies	and	again	
localize	gold	nanoparticles	in	a	single	line. 
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  Immunochromatographic lateral flow assays, 
specifically in the case of pregnancy tests, are robust in 
their stability and detection ranges, further adding to 
their global popularity. From the simplistic pregnancy 
test design that is dependent only on the presence of 
hCG, pregnancy tests can be used to monitor the 
activity of any system in which there is a change in 
hCG release or concentration. Currently, this is limited 
to the hCG found in samples from pregnant women; 
however, this system can be adapted to the previously 
described OSD probes. In the OSD reaction, the strand 
that is released from the OSD probe in the presence of 
the LAMP amplicon loop is subject to any standard 
nucleic acid modifications. One such modification is 
the conjugation of the released strand to any desired 
protein, a feat which can be easily achieved by a variety 
of tagging methods. For example, a SNAP-tag can be 
used.  
 In SNAP-tag biochemistry, a protein known as 
human DNA repair protein O6-alkylguanine-DNA 
alkyltransferase (hAGT) is co-expressed with another 
protein of interest through the use of synthetic gene 
vectors. hAGT provides a reactive cysteine residue 
which is then able to transfer and form an irreversible 
covalent bond with alkyl or benzyl groups from 
substrates that include O6-alkylguanine-DNA and O6-
benzylguanine (BG). Traditionally, this system is taken 
advantage of by producing fluorescent molecules 
conjugated to benzyl group of BG which then become 
covalently linked to the hAGT SNAP-tag and thus to 
the target protein. In modifying this system, 
oligonucleotides can also be synthetically produced 
such that desired strands are similarly bound to BG. 
Thus, it is possible to conjugate a specific nucleic acid 
strand to an equally specific by utilizing the SNAP-tag 
(Figure 4). 
Combining these ideas together, conjugation of 
hCG to an OSD probe can be utilized to selectively 
release hCG in the presence of LAMP amplicon loops, 
which again corresponds to the sole amplification of a 
given nucleic acid biomarker. Subsequent strand-
displacement of the hCG-bearing strand can then be 
monitored using a commercial pregnancy test, just as if 
the hCG in solution had been a result of hCG released 










Combining these ideas together, it is possible to 
design a system in which LAMP is first used to 
specifically amplify nucleic acid biomarkers and 
produce characteristic loop amplicons. Next, using the 
principles of strand displacement, a synthetic 
oligonucleotide reporter probe can be produced such 
that the probe releases an hCG-bearing strand in the 
presence of target LAMP amplicons. Biotinylation of 
this probe can allow for its controlled localization in 
efforts to sequester the undesired activity of unreleased 
hCG. Any hCG thereby released into solution by the 
OSD reaction can then be ran on a pregnancy test strip 
in which the final readout is an easily quantifiable 
colorimetric signal. This system could thus potentially 
be used to provide yes-or-no diagnostic readings for 





 Production of the diagnostic pathway began 
with the expression of the hCG-SNAP protein. This 
series of experiments was completed by the collective 
works of Dr. Yan Du, Dr. Arti Pothukuchy, and Jimmy 
Gollihar. Expression was conduced in mammalian 
cells. After expression and purification, final hCG-
SNAP product was ran on an SDS-PAGE gel (Figure 
5, A). Note that the alpha and beta bands for the hCG 
protein indicate the two components of the 
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realized specifically on the beta component. Upon 
successful expression, the conjugation of the hCG-
SNAP protein with the benzylguanine-modified 
oligonucleotide of the final OSD probe was performed. 
Note that the nucleic acid sequences used for the 
eventual production of the hCG-OSD probe were 
specific to the Zaire Ebola virus gene biomarker 
ZEBOV-VP30. After purifying the conjugated product, 
both the unconjugated and conjugated hCG-SNAP 
proteins were run on an SDS-PAGE gel to verify 
successful binding (Figure 5, B). Additional 
characterization studies were performed upon 
completing the expression and purification processes 
but were excluded to focus on primary product 
validation experiments.   
Once conjugation was complete, verification of 
the hCG-oligonucleotide binding capabilities with anti-
hCG antibodies was conducted and compared relative 
to a commercial hCG without any modification (Figure 
6, A&B). Testing was conducted by Dr. Yan Du. This 
was achieved using an enzyme-linked immunosorbent 
assay (ELISA) in which the capture and enzyme-linked 
antibodies chosen for the assay corresponded to the 
primary and secondary anti-hCG antibodies used in a 
standard pregnancy test.  In observing the results from 
the ELISA, it is apparent that the in-house synthesized 
hCG-oligonucleotide conjugate had a dissociation 
constant (Kd) value equal to 1.0 nM of conjugated 
protein. Alternatively, the Kd or the commercially 
obtained unmodified hCG was equal to 45.5 nM of 
protein.  
After demonstrating the binding performance 
of the hCG-oligonucleotide to standard anti-hCG 
antibodies (as would be found on a pregnancy test 
strip), production of the three-way junction hCG-OSD 
probe was conducted. The initial design for the hCG-
OSD probe was a duplex structure of two partially 
complementary sequences in which the biotinylated 
strand was designed to target one of the four loop 
regions of the ZEBOV-VP30 LAMP amplicon and the 
other strand was the conjugated hCG-oligonucleotide. 
This probe was subsequently used in LAMP product-
detection experiments. At first, increasing 
concentrations of a mimic LAMP target (short 







Figure	6.	 ELISA	 comparison	of	 commercial	 and	oligonucleotide-conjugated	hCG	 to	pregnancy	 test	 antibodies.	Dose	 response	 curves	were	
generated	for	the	in-house	hCG-oligonucleotide	conjugate	(A)	and	a	commercially	purchased	hCG	sample	(B).	The	corresponding	Kd	values	were	
1.0	nM	and	45.5	nM,	respectively.	Figure	obtained	from	Dr.	Yan	Du.			 
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region of the LAMP amplicon) were incubated with the 
hCG-OSD probe. After separating the sample fluid 
from any unreacted hCG-OSD probes through 
magnetic bead collecting, the subsequent hCG release 
was monitored using commercial pregnancy test strips 
(Figure 7, A). Computational quantification of the band 
intensities relative to the control band were then 
determined using Image J software. This data was used 
to plot the signal intensity from the pregnancy tests as 
a function of the concentration of mimic target used to 
release the hCG-bearing strand from the hCG-OSD 
probe (Figure 7, B).  
In transitioning to the product from actual 
LAMP reactions on the ZEBOV-VP30 gene, it was 
discovered that signal for all positive controls was 
being quenched. As such, a new design for the OSD 
probe was achieved through the use of a three-way 
junction. In this setup, a biotinylated strand (termed P2) 
was partially duplexed with high complementarity to 
an unmodified strand (termed P3). The biotinylated 
strand had a sequence that was target-specific to one of 
the loop regions of the LAMP amplicons but also 
contained a non-complementary sequence attached to 
its end. Likewise, at the same end, the P3 strand was 
also tagged with a non-complementary sequence 
different from that of the P2 strand. The result of this 
was a partial duplex: one end contained a toe-hold 
suitable for binding to LAMP amplicons and initiating 
strand displacement; the other end extended two 
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oligonucleotide tags that could thus serve to bind a 
third strand. As such, this final strand was a newly 
synthesized hCG-conjugated oligonucleotide (termed 
P1) that had a complementary sequence to the random 
tags of P2 and P3, thereby forming a three-way junction 
(Figure 10). Since the random tag added to the end of 
P2 was much shorter than that of P3, there was minimal 
binding between P1 and P2, thus allowing P3 to serve 
mostly as the linker in this novel probe design. With 
this system, binding of the P2 strand to a LAMP 
amplicon was expected to cause for complete 
disassembly of the junction.  
Once developed, verification of the three-way 
junction hCG-OSD probe formation was achieved 
using a native PAGE gel in which samples were not 
denatured prior to running (Figure 8). Furthermore, the 
appropriate hCG-release mechanism was also tested 
using short synthetic oligonucleotide fragments that 
mimicked the loop region of the LAMP amplicon 
product targeted by the hCG-OSD probe. In Lane 1, the 
hCG-bearing P1 strand and magnetic bead-bearing P2 
strand were incubated. In Lane 2, P2 and the 
connecting strand P3 were incubated. In Lane 3, P1 and 
P3 were incubated. In Lane 4, the mimic LAMP target 
and P2 were incubated. In Lane 5, the mimic target and 
P1 were incubated. In Lane 6, all three components of 
the three-way junction hCG-OSD probe were 
incubated: P1, P2, and P3. In Lane 7, all three  
components of the three-way junction hCG-OSD probe 
and the mimic LAMP target were incubated. 
After ensuring the successful formation and 
function of the three-way junction hCG-OSD probe, 
actual LAMP product was produced and used for 
further experiments. This was done by performing 
LAMP reactions directly on copies of the ZEBOV-
VP30 gene. To do so, LAMP primers designed 
specifically for the ZEBOV-VP30 gene were used. The 
amount of initial copies of nucleic acid biomarkers 
used for the LAMP reactions ranged from 20 to 20,000 
molecules. In addition to this, two controls were also 
performed by attempting the LAMP and OSD reactions 
on 500,000 initial copies of the melanoma biomarker 
Figure	9.	Pregnancy	test	three-way	junction	hCG-OSD	probe	detection	with	actual	LAMP	product	(designed	for	ZEBOV-VP30	biomarker.)	(A)	Raw	
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gene BRAF. The first control utilized LAMP primers 
specific to the ZEBOV-VP30 gene whereas the second 
utilized primers specific to the BRAF gene. For all 
samples, including both controls, hCG-OSD probes 
specific to the ZEBOV-VP30 gene were added and 
allowed to incubate. After doing so, unreacted probes 
were collected using a magnetic separator and the 
remaining samples were run on individual pregnancy 
test strips. Band intensity was again determined for the 
LAMP reactions. This entire process was conducted for 
LAMP reactions both in buffer (Figure 9, A&B) and in 




 While additional characterization studies were 
conducted to asses the expression and purification 
quality of the hCG-SNAP protein, the overall success 
of the conjugation reaction between the synthesized 
hormone and the BG-modified P1 strand of the final 
OSD probe was demonstrated from the PAGE gel 
(Figure 5, A&B). This was assumed from the observed 
increase in molecular weight corresponding to the 
weight of the BG-oligonucleotide for the band of the 
beta-segment of the hCG protein. This can be further 
understood from the constant molecular weight of the 
alpha-segment of the protein, as the alpha fragment did 
not have a SNAP-tag co-expressed. 
 Once protein expression and conjugation was 
successfully verified, the binding capabilities of the 
hCG-oligonucleotide to the antibodies found in a 
standard pregnancy test then needed to be checked. 
From the ELISA, it was demonstrated that the Kd 
decreased for hCG-antibody binding when comparing 
the conjugated hCG-oligonucleotide relative to the 
unmodified hCG protein (Figure 6). While the decrease 
in Kd indicated improved binding favorability of the 
hCG-oligonucleotide to the pregnancy test strip 
antibodies, the difference in Kd values spanned only a 
single order of magnitude. As such, the slights variants 
in Kd were considered beneficial but relatively 
insignificant. More importantly, however, it was 
determined that the Kd had not been worsened for hCG 
binding as a result of conjugation with the 
oligonucleotide. This thereby allowed for the hCG-
oligonucleotide to act as a viable reporter. 
Using the initial duplexed hCG-OSD probe 
design, it was then appropriate to determine the ability 
of pregnancy tests to monitor the capability of the 
probes to release hCG in the presence of its target. By 
incubating various concentrations of the mimic LAMP 
product with the hCG-OSD probe and running 
subsequent samples on pregnancy test strips (Figure 7, 
A&B), it can be shown that a direct linear relationship 
existed between the logarithmic concentration of 
LAMP target and the subsequent relative band intensity 
of the pregnancy test strip. Since hCG-release is 
directly correlated to the concentration of LAMP 
target, in the range of sample concentrations being 
tested, it was expected that an exponential increase in 
pregnancy test signal would exist as a function of the 
mimic LAMP product concentration. This is 
characteristic for lateral flow assays in the detection of 
their target analytes. As such, since this trend was 
observed, it can be inferred that the hCG-releasing 
system was successfully achieved in the presence of 
mimic LAMP targets and that this signal was capable 
of being monitored using pregnancy tests. 
 When transitioning from the mimic LAMP 
target to actual LAMP product, it was eventually 
discovered that no positive LAMP controls produced a 
measurable signals on any pregnancy test strips, 
contrary to the expectation. In reviewing the OSD 
design, it was discovered that the duplex hCG-OSD 
probe was still capable of releasing the hCG-bearing 
strand in the presence of the desired loop amplicon 
from actual LAMP product; however, it was 
determined that the released hCG-oligonucleotide was 
then binding to a different single-stranded loop 
amplicon. This was thought because the LAMP 
amplification process produces four distinct loop 
regions that are two pairs of sequence complements. As 
such, since the biotinylated strand of the duplexed 
hCG-OSD probe is complementary to one of the loop 
targets, the released hCG-oligonucleotide strand was 
also complementary to a different loop target. It was 
thus hypothesized that binding of the hCG-
oligonucleotide to additional LAMP product caused for 
the formation of a complex that was then too large to 
flow down the pregnancy test strip, thereby leading to 
the lack of presumed signal. Thus, it was necessary to 
design a new OSD probe in which the hCG-bearing 
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strand had no sequence complementarity to any LAMP 
product. This was achieved using the three-way 
junction design, which was then necessary to verify in 
terms of its structure and hCG-release capabilities. To 
do so, various combinations of the three-way junction 
hCG-OSD probe components and mimic LAMP 
product target were incubated together and observed on 
a native PAGE gel (Figure 8). Based on the results, 
several insights into the design of the three-way 
junction hCG-OSD reporter were revealed. As 
expected, from Lanes 1, 2, 3, and 6, it was showed that 
strands P1 and P2 were not able to form a stable 
complex without the presence of strand P3. 
Furthermore, from Lane 4 and 5, it was demonstrated 
that the strand of complementarity to the LAMP target 
was the P2 strand, which was synthesized to bear the 
biotin modification. Lastly, in comparing Lane 6 to 
Lane 7, it was shown that there was significantly 
release of the hCG-bearing P1 strand in the presence of 
the hCG-OSD probe and mimic LAMP product.   
 Confirmation with mimic LAMP targets then 
allowed for future experiments using the product of 
actual LAMP reactions on desired nucleic acid 
biomarker samples. In analyzing the results obtained 
from such experiments, it was observed that the three-
way junction hCG-OSD probe was able to successfully 
produce a measurable signal on pregnancy test strips 
for as low as twenty starting molecules of target gene 
biomarker after undergoing the LAMP reaction (Figure 
9). This was appreciable in LAMP reactions conducted 
both in buffer and in 5% human serum. In both cases, 
background signal from the negative control (using 
LAMP reactions conducted with no initial template) 
showed significantly lower signals from those with the 
appropriate ZEBOV-VP30 gene. Furthermore, both the 
LAMP and OSD selectivity was demonstrated using 
the substitute BRAF target in which no appreciable 
signals were produced in the absence of either the 
correct LAMP primers or OSD probe. In these control 
samples, the background signal produced was within 
similar ranges to those of the negative controls, 
indicating weak competitive signals from non-target 
genes. Signal differences between buffer and serum 
experiments were minimal, thereby showing the low 
influence of a biologically-active background matrix 
on both the capability to perform LAMP and the ability 





 Overall, from the results of this series of 
experiments, each step of the diagnostic pathway was 
synthesized and verified. It is evident that the system is 
successful in which a standard pregnancy test is 
capable of monitoring hCG-release from an OSD probe 
that is designed to specifically respond to LAMP 
amplicons produced from trace amounts of a target 
nucleic acid biomarker gene. While this was 
demonstrated using the ZEBOV-VP30 gene, with 
slight modifications to adjust for various sequences and 
different thermodynamic favorability, the potential 
exists for this method to be applied to an immense 
range of pathological conditions in which nucleic acids 
serve as the primary biomarker. This diagnostic 
technique thus offers a highly programmable, robust, 
and target-specific method for detecting desired nucleic 
acids. The simplicity of its design and its integration 
with a standard pregnancy test allows for a user-
friendly interface that could easily be compounded into 
a single diagnostic device that requires only sample 
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reduced to a proposed thirty-minute window from 
sample input to result readout.  Furthermore, the cost 
of manufacturing such devices is projected to be low 
enough to allow for widespread use in virtually all 
areas of the world. Because of these qualities, the 
described method functions as an ideal tool for both 
point-of-care and low-resource diagnostics.  
 Future directions involve the experimentation 
of the aforementioned downstream goals. This includes 
optimization of reaction kinetics, times, temperatures, 
and reagents for ultimate integration into a single 
device. Additionally, the design of the three-way 
junction OSD probe must also be further investigated 
to achieve results such as the discrimination of SNPs. 
Beyond this, the robustness of the three-way junction 
hCG-OSD probe under lyophilized conditions must 
also be verified to ensure the long-term stability of the 
probe as well as its ability to be used in a diverse span 
of environmental conditions. Once all reaction 
functionality is verified and optimized using in vitro 
samples, future testing can then be conducted using 
samples obtained from patients with actual diseases of 
interest. After completing the remainder of these 
experiments, the production of a finalized diagnostic 
device could then be realized. In doing so, the diagnosis 
of nucleic acid biomarkers may be extensively 
improved, universally impacting global healthcare.  
 
Methods 
All chemicals were of analytical grade and were 
purchased from Sigma-Aldrich (St. Louis, MO, USA) 
unless otherwise indicated. All enzymes and related 
buffers were purchased from New England Biolabs 
(NEB, Ipswich, MA, USA). AccuMed ® Pregnancy 
(HCG) Test Strips were ontained and ordered through 
Amazon. Methods are only briefly highlighted to 
demonstrate general practices implemented throughout 
experiments. Full details are further excluded for the 
purpose of simplicity. Also note that only experiments 
essential to the diagnostic pathway creation or 
repetitive validation were mentioned.  
 
hCG SNAP-Protein Expression 
 
 Production of the hCG SNAP-Protein was 
achieved largely through the collaborative works of Dr. 
Yan Du, Dr. Arti Pothukuchy, and Jimmy D. Gollihar 
of the Ellington Laboratory. First, a gene vector was 
prepared which contained the sequence for both 
components of hCG. Attached to this vector was the 
gene encoding for a SNAP-tag. Vector transformation 
and subsequent protein expression in a mammalian cell 
culture resulted in the production of the SNAP-labeled 
hCG. This protein was purified from the cell culture 
lysate and was utilized in future experiments. 
Verification of successful expression was also 
conducted entirely by the works of Dr. Yan Du.  
 
hCG-Oligonucleotide Conjugation and Three-Way 
Junction hCG-OSD Probe Production 
 
 Production of the conjugated hCG-
oligonucleotide, later used in the hCG-OSD probe, was 
achieved largely through the collaborative works of Dr. 
Yan Du and Dr. Arti Pothukuchy. All oligonucleotide 
components were designed using PrimerExplorerV4 
(Eiken, Japan) software and were all ordered through 
Integrated DNA Technology (IDT, Coralville, IA, 
USA). Future hCG-bearing oligonucleotides strands 
were ordered specifically with a benzylguanine-tag 
(BG-tag) modification. Incubation of these 
oligonucleotides in excess with the synthesized hCG-
SNAP proteins resulted in the covalent linkage of the 
two. Purification of the conjugated hCG-
oligonucleotide from the unconjugated hCG-SNAP 
protein was achieved using fast-performance liquid 
chromatography (FPLC). For the three-way junction 
hCG-OSD probe, the remainder of the production was 
achieved by first incubating the biotinylated P2 strand 
with magnetic streptavidin beads. This was conducted 
on a rotator at room temperature for thirty minutes. 
During this time, the biotin and streptavidin beads were 
allowed to hybridize. A magnetic separator was used to 
collect the hybridized structure and was washed several 
times with high volumes of PBS buffer. After this, the 
final three-way junction hCG-OSD probe was 
assembled by adding the remaining two strands, P1 and 
P3, to the sample and then allowing the mixture to 
incubate for 1.5 hours at room temperature on a rotator. 
The constructed probes were again collected with a 
magnetic separator and washed several times with PBS 
buffer. The final hybridized three-way junction hCG-
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OSD probe sample was resuspended in PBS buffer and 
stored at 4ºC for future use.  
 
LAMP Reaction Preparation  
 
Mixtures were prepared to contain the 
following reagents: different copies of nucleic acid 
biomarker templates of clinical relevance (Ebola virus, 
melanoma cells, etc.), all six primers necessary for the 
LAMP reaction, betaine, MgCl2 solution, and dNTPs. 
Note that the nucleic acid biomarkers were 
synthetically produced but were identical to sequences 
found in patient samples. Depending on the 
experimental constraint, certain samples were tested in 
solutions containing human serum, saliva, or other 
biological matricies. Samples were heated to denature 
any undesired secondary structures and to treat for any 
contamination. After heating, samples were followed 
with a chilling on ice to restore ambient temperatures. 
Upon cooling, Bst DNA polymerase 2.0 was added to 
each sample to initiate the LAMP reaction. Total 
reaction volumes were held at 30 µL in Isothermal 
Buffer. Samples were incubated for 1.5 hour in a 
thermal cycler maintained at 65 °C. Once complete, 
samples were briefly heated to 80ºC to heat-kill the Bst 
DNA polymerase, thus halting the reaction. Terminated 
LAMP reactions were stored at 4ºC until needed for 
future experiments. Note that all LAMP reactions were 
performed to completion, meaning that reactions were 
conducted until all available primers were depleted. As 
such, it was expected that final LAMP product 
concentration would be equal in all samples, as product 
concentration was dependent only on reagent 
availability and was independent of initial target 
amount.  
 
Strand Displacement Reactions and Pregnancy Strip 
Testing 
 
 hCG-OSD probes hybridized to magnetic beads 
were washed prior to use and were resuspended in 
samples of interest (either solutions of mimic LAMP 
amplicon oligonucleotides or the product of actual 
LAMP reactions.) These samples were allowed to 
incubate on a rotator for thirty minutes at room 
temperature. During this time, any strand-displacement 
of the hCG-bearing strand was able to occur. Upon 
incubation completion, a magnetic separator was used 
to retract and condense any remaining hCG-OSD 
probes. The residual solution, containing any free hCG, 
was removed and set aside in new tubes for subsequent 
testing. Pregnancy test strips were directly dipped into 
samples and were allowed to develop for around two 
minutes after lateral flow was complete. Standard cell-
phone cameras were used to photograph the resulting 
bands that formed on pregnancy test strips. Image J 
(NIH, USA) software was used to quantify the intensity 
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